Table S3.
Botanical Medicine Modulation of Vaccine Efficacy
| Dosage | Timing (before/after vaccination) | Control | Population | Vaccine Type | Outcome | Citation | |
|---|---|---|---|---|---|---|---|
| JTT (Kampo) | 3.75 g JTT formula containing astragalus, cinnamon, Panax ginseng, licorice and others BID Total daily dose 7.5g | 4 weeks before and 24 weeks after vaccination | No supplementation | 65+ years n=90 |
TIV | Significantly increased antibody titers for H3N2 but not other strainsa | Saiki et al35 |
| JTT (Kampo) | 15 mg JTT formula containing astragalus, cinnamon, Panax ginseng, licorice and others daily | 35 days during first cycle of vaccinations | No supplementation | 50-83 year; median age 66 Advanced pancreatic cancer patients undergoing peptide vaccination n=57 |
Personalized peptides based on HLA typing and IgG titers | No significant change in vaccine responseb | Yutani et al36 |
| Chinese wolfberry (Goji berry) | 13.7 g lacto-wolfberry supplement containing 530 mg/g wolfberry fruit, 290 mg/g bovine skimmed milk, 180 mg/g maltodextrin daily | 1 month before and 2 months after vaccine | 13.7 g/d placebo containing 290 mg/g bovine skimmed milk, 200 mg/g maltodextrin, 476 mg/g sucrose, and 34 mg/g colorants. | 65-70 years n=150 |
TIV | Significantly increased total and influenza-specific antibody levelsa | Vidal et al37 |
aSignificant effect on/association with vaccine response for at least one vaccine strain/subgroup;
bNo significant effect on/association with vaccine response